Smithfield BioScience Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Smithfield BioScience's estimated annual revenue is currently $7M per year.(i)
  • Smithfield BioScience's estimated revenue per employee is $155,000

Employee Data

  • Smithfield BioScience has 45 Employees.(i)
  • Smithfield BioScience grew their employee count by 15% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M50%N/AN/A
#2
$1.7M110%N/AN/A
#3
$0.8M50%N/AN/A
#4
$5.1M3314%N/AN/A
#5
$64.6M4172%N/AN/A
#6
$1.7M11-8%N/AN/A
#7
$0.8M50%N/AN/A
#8
$7.4M48-41%N/AN/A
#9
$0.6M40%N/AN/A
#10
$0.9M1220%N/AN/A
Add Company

What Is Smithfield BioScience?

Smithfield Foods is committed to producing Good Food. Responsibly.® Part of that responsibility is making sure we utilize the entire animal and minimize waste. There are many parts of the animal that are not typically eaten. However, at Smithfield, we have found valuable uses for these parts, such as supplying them to the medical community. Smithfield BioScience is part of a vertically integrated platform providing an unparalleled level of traceability and product safety, while offering innovative solutions to increase functionality and viability of Smithfield’s non-food products for the advanced development of pharmaceuticals, nutraceuticals, and medical devices. Smithfield Foods continues to invest in its BioScience unit and is one of the only U.S. manufacturers of Heparin Sodium USP. In Cincinnati, we have a USDA-approved and FDA-registered facility with significant expansion plans. The facility manufactures products used in cardiac surgery, dialysis procedures, blood transfusions, medical device implantation, and many other applications.

keywords:N/A

N/A

Total Funding

45

Number of Employees

$7M

Revenue (est)

15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.9M457%N/A
#2
$8.7M455%N/A
#3
$8.2M455%N/A
#4
$9.7M457%N/A
#5
$3.5M45-32%N/A